Arcus Biosciences Inc. (RCUS)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
3 |
$15,402,661 |
| Sells |
2 |
$56,989 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 27 Feb 2025 |
KANEKO YASUNORI |
Director |
27 Feb 2025 |
20,000 |
10.06 |
201,200 |
| 27 Feb 2025 |
ROSEN TERRY J |
Chief Executive Officer |
27 Feb 2025 |
19,800 |
10.18 |
201,465 |
| 20 Feb 2025 |
GILEAD SCIENCES, INC. |
10% |
18 Feb 2025 |
1,363,636 |
11.00 |
14,999,996 |
| 31 Jan 2024 |
GILEAD SCIENCES, INC. |
10% |
29 Jan 2024 |
15,238,095 |
21.00 |
319,999,995 |
| 30 Jun 2023 |
GILEAD SCIENCES, INC. |
10% |
28 Jun 2023 |
1,010,000 |
19.26 |
19,452,600 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock